Academy Honors Scientists for Malaria, Battery, and Climate Research

His work has significantly advanced the understanding of malaria biology and the mechanisms of drug resistance.

This prestigious award recognizes his profound contributions to developing new strategies against a disease that continues to pose a major global health challenge.

A collaboration between WEHI and MSD encountered significant funding challenges, as MSD provided in-kind support but no direct financial contributions to the research. All work undertaken by MSD within this partnership also required external funding to proceed.

The initial stages of the project were made possible by a $280,000 grant from the Welcome Trust, highlighting the necessity of diverse funding streams for ambitious medical research. This model underscores the complexities of financing large-scale scientific collaborations, particularly when major pharmaceutical partners cannot offer direct monetary support.

Securing external grants becomes crucial for sustaining the research momentum and covering operational costs.

Several promising malaria drug candidates are progressing through clinical development, offering new hope for treatment. MK7602 is set to enter Phase 2 clinical trials in Uganda early next year, in 2027, marking a significant step toward its potential deployment.

Another candidate, MK3868, is being explored for its potential as a single-dose cure, which could revolutionize malaria treatment by simplifying administration and improving patient adherence. Additionally, WM163 is under development as a long-acting injectable, aiming to provide extended protection and therapeutic benefits against the disease.

These advancements underscore a multi-pronged approach to combating malaria, targeting both acute treatment and long-term prevention.

Research confirmed that plasmepsin 9 and 10, critical targets for malaria drugs, exhibit no polymorphisms, indicating their absolute conservation across parasite species. This genetic stability is vital because it suggests these targets are less likely to develop resistance to new treatments.

Laboratory tests designed to select for resistance to drugs targeting these plasmepsins ultimately failed, reinforcing their robust nature. This finding offers significant optimism for the long-term efficacy of drugs developed to inhibit these specific parasite proteins.

The high conservation of these targets reduces the risk of rapid drug resistance evolution, a persistent challenge in malaria control.

Professor Xiao-Ping Guo received the 2026 Ruby Payne-Scott Medal, recognizing her exceptional contributions to energy storage and conversion. Her research focuses on identifying the physical and chemical properties of functional materials to enhance the performance of batteries and other energy storage devices.

Professor Guo's work is crucial for advancing cleaner energy solutions, aiming to improve both the efficiency and longevity of next-generation power sources.

Significant progress is being made in battery technology with the development of lithium metal batteries incorporating solid-state electrolytes, which substantially improve safety. These advanced batteries are well-suited for high-energy applications such as long-range electric vehicles and low-altitude aircraft.

Additionally, researchers are developing low-cost, aqueous zinc-ion batteries specifically designed for stationary energy storage, offering a more sustainable option for grid-scale applications. These innovations address the growing demand for safer and more efficient energy solutions across various sectors.

Further efforts are focused on green chemical recycling methods that use temperature and water control to efficiently separate critical metals from used batteries. This approach aims to reduce environmental impact and promote a circular economy for battery materials.

Professor Guo employs advanced techniques, including synchrotron and neutron radiation, to meticulously analyze the internal structures and properties of these battery materials. This detailed analysis is vital for optimizing their performance and understanding degradation mechanisms.

While the solid electrolyte interface (SEI) is widely used to stabilize battery cycling, it suffers from brittleness and slow ion diffusion, which can limit battery performance. A newer approach, the liquid electrolyte interface (LEI), offers a significant improvement.

LEI exhibits self-healing properties, leading to better adhesion to electrode surfaces and prolonged stability during charge and discharge cycles. This characteristic helps mitigate the degradation issues common with SEI, enhancing overall battery longevity.

Crucially, LEI maintains higher ion diffusivity throughout the battery's operational cycles, enabling more efficient energy transfer and contributing to improved power output.

Professor Philip Gale's research focuses on developing innovative synthetic molecules capable of directly transporting anions across cell membranes. These small molecules are engineered to encircle anions, providing them with an oily coating that enables them to pass through biological membranes.

This approach offers a novel therapeutic strategy for diseases like cystic fibrosis, where chloride channels are often absent or dysfunctional. By creating an alternative pathway for anion transport, these molecules could restore crucial cellular functions.

The research also extends to developing anti-cancer agents that utilize similar transport mechanisms to trigger programmed cell death in malignant cells, indicating broad potential for this technology.

For approximately 10% of cystic fibrosis patients, conventional treatments, which rely on correcting faulty chloride channels, are ineffective because these channels are entirely absent from their cell membranes. Synthetic transporters offer a promising alternative by functioning independently of the existing biological channels.

This innovative approach could provide a future treatment pathway for these patients who currently have limited therapeutic options. By bypassing the need for functional biological channels, synthetic transporters address a critical gap in cystic fibrosis care.

Experiments confirmed that the introduction of synthetic transporters, facilitating the influx of chloride into cells, directly impacts cell viability. This effect was observed as a decrease in the number of living cells when exposed to a chloride buffer, providing strong evidence for the transporters' functionality.

Further validation came from tests showing that removing sodium ions from the environment halted the chloride influx process. This demonstrates a clear dependence on counter-ions, as sodium is necessary to balance the electrical charge of the incoming chloride.

The observed mechanisms involve the generation of reactive oxygen species and lysosomal deacidification, which are critical cellular responses triggered by the chloride influx. This collaboration with Yonsei University established the precise actions of these synthetic molecules.

This evidence supports that cell viability is being affected by influx of chloride into the cells.

Professor Hala Zreiqat highlighted a significant shift in the funding landscape for Australian research, noting that her projects had been heavily supported by the NHMRC for 25 years. However, she has not been able to secure funding from the system since 2021, describing the situation as 'dry.'

To continue her research, Professor Zreiqat successfully secured new funding through the Swiss National Foundation, achieved via a collaboration with ETH Zurich. This shift underscores the increasing reliance on international partnerships and funding bodies for sustained scientific endeavors in Australia.

She emphasized that her involvement in commercial spin-offs from her research carries no personal financial interest, focusing solely on the scientific and public health benefits.

Nominations are a crucial part of the selection process for these prestigious awards.

Below this threshold, wetlands have a reasonable chance to maintain their current boundaries, but beyond it, they face disorganized retreat across the landscape.

Historical data supports this, showing that coastal wetlands collapse when sea level rise exceeds this 7mm/year rate. This rate is also a recognized threshold for coral islands, indicating a shared vulnerability among diverse coastal ecosystems.

Projections suggest that global warming between 2-3 degrees Celsius could trigger this accelerated rate of sea level rise, putting vast areas of coastal wetlands at risk. Currently, mangroves play a vital role as carbon sinks, absorbing significant amounts of atmospheric carbon dioxide.

The loss of these ecosystems would not only diminish biodiversity but also reduce natural defenses against climate change.

For the first time in recent memory, the past decade has seen an increase in mangrove coverage, reversing previous trends of precipitous decline. This positive shift is largely attributed to concerted conservation efforts and new initiatives.

Blue carbon initiatives are now a key driver for mangrove restoration, providing both environmental and economic incentives for preserving these vital ecosystems. The focus on blue carbon has mobilized significant resources and attention toward coastal wetland habitats.

These initiatives focus on reopening environments previously protected from flooding to allow mangroves and tidal marshes to recolonize.

This strategy enables restoration at scale, leading to substantial carbon sequestration. The additional carbon captured by these restored ecosystems can then be traded through schemes like Australian carbon credit units.

These financial incentives are proving to be a crucial driver for encouraging widespread action in ecosystem restoration. The ability to monetize carbon absorption transforms conservation into an economically viable endeavor, encouraging broader participation and investment.

By making restoration financially attractive, these methods are accelerating the pace of environmental recovery and promoting sustainable land use practices.

A significant challenge in global healthcare is the lack of international consensus on anemia thresholds, leading to inconsistent clinical diagnoses across different facilities and regions. This means a patient could be diagnosed with anemia at one hospital and not at another, purely due to varying diagnostic criteria.

To address this, an international analysis of high-quality data from healthy populations informed the development of new, standardized global diagnostic criteria. These new guidelines are currently being implemented worldwide to improve the accuracy and consistency of anemia diagnoses, aiming to harmonize clinical practice and patient care.

Research is increasingly recognizing heavy menstrual bleeding (HMB) as a more significant predictor of iron deficiency than nutritional factors, challenging the traditional view that iron deficiency is solely a dietary problem. Each milliliter of blood contains half a milligram of iron, making sustained HMB a substantial source of iron loss.

HMB also causes considerable social disruption and impacts the quality of life for millions, yet there is a lack of global epidemiology and clear clinical guidelines for its management. This gap in understanding and treatment has led to renewed focus on this issue.

New funding from the Gates Foundation will support research into the determinants and solutions for HMB, particularly focusing on adolescents in South Asia. This initiative aims to develop comprehensive strategies to address this overlooked public health challenge.

Liquid biopsy techniques are becoming routine for molecular profiling in major international markets for lung, colorectal, and breast cancers. This technology allows for less invasive and more frequent monitoring of cancer characteristics, guiding treatment decisions effectively.

Minimal residual disease (MRD) monitoring is currently integrated into clinical trials, providing crucial data to inform treatment escalation or de-escalation strategies. This application helps clinicians tailor therapies based on the presence of residual cancer cells after initial treatment.

However, early cancer screening through blood tests remains further away from standard clinical adoption. Challenges in sensitivity, specificity, and extensive validation are still being addressed before it can become a routine part of general cancer detection.

Sarah Jane Doson notes that molecular profiling is truly routine in lung, colorectal, and breast cancers overseas. The next application around MRD monitoring is well and truly embedded in clinical trials now.

Jacob Burch received the Aboriginal and Torres Strait Islander Scientist Award, marking a significant personal and professional milestone. As the first person in his family to attend university, this prestigious recognition is a great honor, acknowledging both his individual achievements and the legacy of his predecessors.

His work focuses on climate resilience through the study and application of native grains, aiming to integrate food security with Indigenous sovereignty. This approach seeks to leverage traditional knowledge and biodiversity to address contemporary environmental and societal challenges.

Geodomics modeling has advanced our understanding of sea level rise, clarifying that water does not simply rise uniformly like in a bathtub. Instead, melting ice sheets cause localized drops in sea level near the ice mass due to gravitational shifts.

These sophisticated models account for Earth's elasticity and the complex gravitational changes induced by ice melt, providing more accurate regional sea level predictions. This granular approach is crucial for understanding specific coastal impacts and developing localized adaptation strategies.

Beyond sea level dynamics, this research has identified significant correlations between tectonic plate thickness and the distribution of metal deposits, particularly in Australia. This breakthrough has led to the identification of 97 new exploration tenures in Australia.

These findings are transforming mineral exploration strategies by providing targeted insights, reducing the risks and costs associated with traditional discovery methods. The improved models enhance both environmental forecasting and resource management.

Research has identified a key sensor protein within chloroplasts that acts as a 'fire alarm,' enabling plants to detect and respond to heat-induced damage. This sensor activates a protective process within the plant, leading to the closure of leaf pores.

By closing these pores, plants conserve water during periods of drought, significantly enhancing their resilience to adverse environmental conditions. This mechanism is vital for maintaining plant hydration and preventing wilting under stress.

The translation of these laboratory findings into field trials has demonstrated tangible benefits, with observed wheat yield increases of 4-8%. This successful application underscores the practical importance of fundamental scientific discoveries in improving agricultural productivity.

This research highlights the critical need for long-term funding to support fundamental science, as such foundational discoveries often lead to significant practical applications in areas like food security.

Malaria, for instance, has long faced the challenge of drug resistance emerging against nearly every treatment ever used, necessitating continuous research into new therapies.

These mathematical models correlated immunological data with real-world vaccine protection during the COVID-19 pandemic, demonstrating their utility in public health responses. They help researchers predict disease spread, evaluate intervention effectiveness, and optimize vaccination strategies.

By applying rigorous quantitative methods, scientists can gain deeper insights into the complex dynamics of infectious diseases, aiding in the development of more effective control measures. This interdisciplinary approach combines biological understanding with advanced analytical tools.

This finding challenges previous assumptions about the timing of effective health interventions.

Statistical methods were employed to effectively separate the genetic influences of the baby and the mother, revealing that genetics are a primary driver linking birth size to adult health outcomes. This distinction is crucial for understanding the complex interplay of factors determining lifelong health.

Consequently, the focus for reducing childhood cardiovascular risk should shift towards interventions later in childhood, rather than concentrating solely on the prenatal period. This new perspective suggests that postnatal environmental and lifestyle factors may play a more significant role in shaping long-term health.

Nicole Warrington explained that this research shows that intervening on the mother during pregnancy is unlikely to have long-term impacts on the baby in terms of reducing their risk of these cardio diseases in later life. Things like Type 2 diabetes.